IGF2BP2 and acute myeloid leukemia: After AML cells were treated with JQ1, the expressions of IGF2BP2 and IGF2BP3 were both decreased (Figure 1G,H), while the expressions of METTL3, METTL14, FTO and ALKBH5 were not altered (Figure S1H,I).